Girard Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $15.2M | Sell |
27,461
-3,889
| -12% | -$2.23M | 1.44% | 16 |
|
|
2024
Q1 | $18.2M | Buy |
31,350
+2,954
| +10% | +$1.66M | 1.72% | 13 |
|
|
2023
Q4 | $15.1M | Sell |
28,396
-1,454
| -5% | -$704K | 1.53% | 13 |
|
|
2023
Q3 | $15.1M | Buy |
29,850
+1,146
| +4% | +$611K | 1.7% | 11 |
|
|
2023
Q2 | $15M | Sell |
28,704
-309
| -1% | -$167K | 1.58% | 13 |
|
|
2023
Q1 | $16.7M | Buy |
29,013
+845
| +3% | +$476K | 1.85% | 9 |
|
|
2022
Q4 | $15.5M | Buy |
28,168
+135
| +0.5% | +$71.5K | 1.76% | 11 |
|
|
2022
Q3 | $14.2M | Buy |
28,033
+1,200
| +4% | +$672K | 1.89% | 10 |
|
|
2022
Q2 | $14.6M | Sell |
26,833
-727
| -3% | -$400K | 1.86% | 9 |
|
|
2022
Q1 | $16.3M | Buy |
27,560
+3,679
| +15% | +$2.11M | 1.78% | 10 |
|
|
2021
Q4 | $15.9M | Buy |
23,881
+747
| +3% | +$466K | 1.73% | 9 |
|
|
2021
Q3 | $13.2M | Buy |
23,134
+774
| +3% | +$425K | 1.67% | 10 |
|
|
2021
Q2 | $11.3M | Buy |
22,360
+4,603
| +26% | +$2.17M | 1.45% | 15 |
|
|
2021
Q1 | $8.1M | Buy |
17,757
+956
| +6% | +$456K | 1.17% | 24 |
|
|
2020
Q4 | $7.83M | Buy |
16,801
+183
| +1% | +$85.8K | 1.21% | 21 |
|
|
2020
Q3 | $7.34M | Sell |
16,618
-249
| -1% | -$103K | 1.23% | 19 |
|
|
2020
Q2 | $6.11M | Sell |
16,867
-748
| -4% | -$251K | 1.1% | 27 |
|
|
2020
Q1 | $5M | Sell |
17,615
-351
| -2% | -$111K | 1% | 30 |
|
|
2019
Q4 | $5.84M | Sell |
17,966
-96
| -0.5% | -$29.1K | 0.96% | 32 |
|
|
2019
Q3 | $5.26M | Buy |
18,062
+127
| +0.7% | +$36.4K | 0.98% | 33 |
|
|
2019
Q2 | $5.27M | Buy |
17,935
+30
| +0.2% | +$8.26K | 0.93% | 35 |
|
|
2019
Q1 | $4.9M | Sell |
17,905
-782
| -4% | -$195K | 0.91% | 33 |
|
|
2018
Q4 | $4.18M | Sell |
18,687
-392
| -2% | -$92K | 0.88% | 36 |
|
|
2018
Q3 | $4.66M | Sell |
19,079
-1,285
| -6% | -$296K | 0.83% | 33 |
|
|
2018
Q2 | $4.22M | Buy |
20,364
+291
| +1% | +$61.8K | 0.8% | 36 |
|
|
2018
Q1 | $4.14M | Buy |
20,073
+317
| +2% | +$66.5K | 0.97% | 30 |
|
|
2017
Q4 | $3.75M | Sell |
19,756
-98
| -0.5% | -$18.8K | 0.72% | 45 |
|
|
2017
Q3 | $3.76M | Buy |
19,854
+605
| +3% | +$110K | 0.78% | 42 |
|
|
2017
Q2 | $3.36M | Buy |
19,249
+609
| +3% | +$102K | 0.73% | 45 |
|
|
2017
Q1 | $2.86M | Buy |
18,640
+1,304
| +8% | +$199K | 0.69% | 52 |
|
|
2016
Q4 | $2.45M | Buy |
17,336
+548
| +3% | +$80.8K | 0.71% | 47 |
|
|
2016
Q3 | $2.67M | Buy |
16,788
+426
| +3% | +$65.6K | 0.89% | 39 |
|
|
2016
Q2 | $2.42M | Buy |
16,362
+176
| +1% | +$26K | 0.92% | 38 |
|
|
2016
Q1 | $2.29M | Buy |
16,186
+786
| +5% | +$105K | 1% | 32 |
|
|
2015
Q4 | $2.18M | Sell |
15,400
-495
| -3% | -$66K | 1.06% | 30 |
|
|
2015
Q3 | $1.94M | Buy |
15,895
+520
| +3% | +$67.7K | 1.1% | 32 |
|
|
2015
Q2 | $2M | Buy |
15,375
+1,215
| +9% | +$158K | 1.12% | 36 |
|
|
2015
Q1 | $1.9M | Buy |
14,160
+535
| +4% | +$69K | 1.13% | 30 |
|
|
2014
Q4 | $1.71M | Buy |
13,625
+246
| +2% | +$29.9K | 1.07% | 38 |
|
|
2014
Q3 | $1.63M | Buy |
13,379
+730
| +6% | +$88.8K | 1.09% | 35 |
|
|
2014
Q2 | $1.49M | Sell |
12,649
-260
| -2% | -$30.6K | 1.03% | 38 |
|
|
2014
Q1 | $1.55M | Buy |
12,909
+294
| +2% | +$35K | 1.1% | 32 |
|
|
2013
Q4 | $1.41M | Buy |
+12,615
| New | +$1.25M | 1.12% | 33 |
|
Other funds holding TMO
Girard Partners's TMO Position: Q2 2024 in Review
Girard Partners reduced its Thermo Fisher Scientific (TMO) stake by 12% in Q2 2024, selling an estimated $2.23M and leaving 27,461 shares worth $15.2M. The position accounts for 1.44% of the portfolio, ranked #16.
Girard Partners first reported a position in TMO in Q4 2013 and has held it in 43 quarters since. The position peaked at $18.2M in Q1 2024. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.
- Girard Partners held 27,461 shares of Thermo Fisher Scientific worth $15.2M as of Q2 2024.
- Girard Partners sold 3,889 Thermo Fisher Scientific shares in Q2 2024, an estimated $2.23M.
- Thermo Fisher Scientific made up 1.44% of Girard Partners's portfolio in Q2 2024, its #16 holding.
- Girard Partners first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 43 quarters since.
- Girard Partners's Thermo Fisher Scientific position peaked at $18.2M in Q1 2024.
- 2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.
Based on Girard Partners's 13F filing for Q2 2024, filed 12 Aug 2024.